M. Groot

Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia

A. Hagenbeek, B. Löwenberg, M. Oudshoorn, 2002, Bone Marrow Transplantation.

PCN1 COST ANALYSIS OF HLA-IDENTICAL SIBLING AND VOLUNTARY UNRELATED ALLOGENEIC BONE MARROW AND PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN ADULTS WITH ACUTE MYELOCYTIC LEUKAEMIA OR ACUTE LYMPHOBLASTIC LEUKAEMIA

A. Hagenbeek, B. Löwenberg, M. Oudshoorn, 2002 .

Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits.

M. Hanna, G. Bonsel, C. Meijer, 2005, Vaccine.

Cost‐effectiveness of rituximab (MabThera®) in diffuse large B‐cell lymphoma in the Netherlands

J. Hornberger, P. Lugtenburg, P. Huijgens, 2005, European journal of haematology.

Susac’s syndrome as an immune-related adverse event after pembrolizumab: a case report

A. Compter, D. Brandsma, A. J. Langen, 2019, Journal of Neurology.

Costs of prostate cancer, metastatic to the bone, in the Netherlands.

C. U. Uyl‐de Groot, R. Pelger, M. Groot, 2003, European urology.

Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits.

G. Bonsel, P. Verboom, M. Groot, 2005, Vaccine.